Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients. 1985

R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill

Blood pressure measurements were collected from 36 depressed geriatric outpatients (ages 55 to 81 years) enrolled in a double-blind, placebo-controlled study of the efficacy of doxepin and imipramine. Mean systolic postural changes were 25.9 mm Hg for imipramine, significantly higher than the 10.5 mm Hg for doxepin, and 12.4 mm Hg for placebo. The orthostatic drop in the imipramine group was only weakly related to dose and did not correlate with amount of pretreatment orthostatic hypotension or with duration of treatment. The increased orthostatic hypotension occurred early in treatment and at low doses of imipramine. Accordingly, caution is advised in the use of imipramine for the elderly.

UI MeSH Term Description Entries
D007024 Hypotension, Orthostatic A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE. Hypotension, Postural,Orthostatic Hypotension,Postural Hypotension
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004316 Doxepin A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. Apo-Doxepin,Aponal,Deptran,Desidox,Doneurin,Doxepia,Doxepin Hydrochloride,Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5),Doxepin beta,Doxepin-RPh,Espadox,Mareen,Novo-Doxepin,Prudoxin,Quitaxon,Sinequan,Sinquan,Xepin,Zonalon,Apo Doxepin,ApoDoxepin,Doxepin RPh,Hydrochloride, Doxepin,Novo Doxepin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
December 1983, Journal of clinical psychopharmacology,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
March 1991, Journal of psychiatry & neuroscience : JPN,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
April 1969, Current therapeutic research, clinical and experimental,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
January 1982, International pharmacopsychiatry,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
April 1984, The Journal of clinical psychiatry,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
January 1990, International journal of clinical pharmacology research,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
February 1978, The Journal of clinical psychiatry,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
January 1993, Journal of psychiatric research,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
January 1997, Psychopharmacology bulletin,
R E Neshkes, and R Gerner, and L F Jarvik, and J Mintz, and J Joseph, and S Linde, and J Aldrich, and M E Conolly, and R Rosen, and M Hill
April 1965, Archives of general psychiatry,
Copied contents to your clipboard!